We are live on ! Find out more
SRTA

Strata Critical Medical Inc

102 hedge funds and large institutions have $128M invested in Strata Critical Medical Inc in 2023 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 39 increasing their positions, 21 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 21

49% more call options, than puts

Call options by funds: $1.18M | Put options by funds: $794K

44% more capital invested

Capital invested by funds: $89.1M → $128M (+$39M)

2.21% more ownership

Funds ownership: 46.41%48.61% (+2.2%)

7% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 15

3% less funds holding

Funds holding: 105102 (-3)

Holders
102
Holders Change
-3
Holders Change %
-2.86%
% of All Funds
1.49%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
14
Increased
39
Reduced
21
Closed
15
Calls
$1.18M
Puts
$794K
Net Calls
+$390K
Net Calls Change
+$1.05M
Name Holding Trade Value Shares
Change
Change in
Stake
QOP
26
Quinn Opportunity Partners
Virginia
$603K
Charles Schwab
27
Charles Schwab
California
$594K
N
28
Nuveen
North Carolina
$585K +$21.2K +7,402 +5%
GCP
29
GSA Capital Partners
United Kingdom
$580K +$472K +164,314 New
Connor, Clark & Lunn Investment Management (CC&L)
30
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$556K +$294K +102,315 +186%
AQR Capital Management
31
AQR Capital Management
Connecticut
$547K +$445K +154,926 New
Susquehanna International Group
32
Susquehanna International Group
Pennsylvania
$451K +$166K +57,744 +82%
AGC
33
Aspen Grove Capital
Colorado
$441K
UBS Group
34
UBS Group
Switzerland
$385K +$82K +28,566 +36%
Jane Street
35
Jane Street
New York
$377K +$252K +87,644 +456%
AIM
36
Allen Investment Management
New York
$353K
GC
37
Guggenheim Capital
Illinois
$350K -$1.57K -547 -0.5%
Squarepoint
38
Squarepoint
New York
$342K +$214K +74,414 +332%
RhumbLine Advisers
39
RhumbLine Advisers
Massachusetts
$338K +$28.9K +10,065 +12%
Millennium Management
40
Millennium Management
New York
$186K -$709K -247,146 -82%
American Century Companies
41
American Century Companies
Missouri
$180K +$41.7K +14,541 +40%
HSBC Holdings
42
HSBC Holdings
United Kingdom
$179K +$68.4K +23,814 +89%
HF
43
HRT Financial
New York
$155K +$127K +44,176 New
Royal Bank of Canada
44
Royal Bank of Canada
Ontario, Canada
$154K +$38K +13,240 +43%
Stifel Financial
45
Stifel Financial
Missouri
$142K +$71.4K +24,859 +162%
LPL Financial
46
LPL Financial
California
$134K +$23K +8,000 +27%
XT
47
XTX Topco
Cayman Islands
$124K -$14.7K -5,112 -13%
MIM
48
MetLife Investment Management
New Jersey
$114K
SG Americas Securities
49
SG Americas Securities
New York
$112K +$16.2K +5,652 +22%
Deutsche Bank
50
Deutsche Bank
Germany
$111K -$7.02K -2,447 -7%

SRTA Hedge Fund Activity: Q4 2023 in Review

102 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Strata Critical Medical Inc (SRTA) for Q4 2023, worth a combined $128M — up 44% from $89.1M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of SRTA and 14 opened new positions — a net loss of 1 holder — while 21 trimmed existing stakes and 39 added.

The largest buyer was AWM Investment Company, opening a new position worth an estimated $3.99M. The largest seller was State Street, cutting an estimated $2.45M.

  • 102 institutional investors held Strata Critical Medical Inc (SRTA) as of Q4 2023, down from 105 in Q3 2023.
  • Funds reported $128M of Strata Critical Medical Inc stock for Q4 2023, up 44% quarter-over-quarter.
  • 14 funds opened new Strata Critical Medical Inc positions in Q4 2023 and 15 closed out, a net change of -1 holder.
  • The largest Strata Critical Medical Inc buyer in Q4 2023 was AWM Investment Company, an estimated $3.99M added.
  • The largest Strata Critical Medical Inc seller in Q4 2023 was State Street, an estimated $2.45M sold.

Based on aggregated 13F filings for Q4 2023.